US Stock MarketDetailed Quotes

IPHYF INNATE PHARMA

Watchlist

2.245
0.0000.00%

15min DelayClose Sep 25 16:00 ET

181.73MMarket Cap-4923P/E (TTM)

INNATE PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-69.97%-32.56M

67.23%-19.16M

-12.92%-58.46M

-248.23%-51.77M

34.93M

Net income from continuing operations

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

---20.76M

Operating gains losses

156.31%308K

48.69%-547K

-309.02%-1.07M

157.63%510K

---885K

Depreciation and amortization

-88.79%5.09M

887.92%45.41M

-91.91%4.6M

243.62%56.8M

--16.53M

Other non cash items

-95.49%6K

114.35%133K

-301.52%-927K

-10.85%460K

--516K

Change In working capital

-156.67%-32.09M

-26.48%-12.5M

79.91%-9.89M

-222.26%-49.21M

--40.25M

Cash from discontinued investing activities

Operating cash flow

-69.97%-32.56M

67.23%-19.16M

-12.92%-58.46M

-248.23%-51.77M

--34.92M

Investing cash flow

Cash flow from continuing investing activities

999.09%20.63M

304.69%1.88M

93.14%-917K

78.48%-13.37M

-62.12M

Net PPE purchase and sale

62.43%-201K

41.97%-535K

-2.67%-922K

29.35%-898K

---1.27M

Net intangibles purchase and sale

-240.72%-2M

-46.38%-587K

96.13%-401K

83.82%-10.38M

---64.13M

Net investment purchase and sale

658.93%22.77M

--3M

--0

-250.00%-3M

--2M

Net other investing changes

6,500.00%64K

-102.56%-1K

166.10%39K

-490.00%-59K

---10K

Cash from discontinued investing activities

Investing cash flow

999.15%20.63M

304.69%1.88M

93.14%-917K

78.48%-13.37M

---62.12M

Financing cash flow

Cash flow from continuing financing activities

-7.55%-1.97M

-106.82%-1.83M

2,376.57%26.82M

-101.51%-1.18M

77.76M

Net issuance payments of debt

-16.54%-2.36M

-107.61%-2.03M

3,109.15%26.63M

-107.43%-885K

--11.92M

Net common stock issuance

----

--66.01M

Cash dividends paid

--0

Proceeds from stock option exercised by employees

99.49%395K

-60.32%198K

939.58%499K

9.09%48K

--44K

Net other financing activities

----

0.00%1K

--1K

Cash from discontinued financing activities

Financing cash flow

-7.55%-1.97M

-106.82%-1.83M

2,378.59%26.82M

-101.51%-1.18M

--77.77M

Net cash flow

Beginning cash position

-18.82%84.23M

-24.15%103.76M

-32.58%136.79M

33.20%202.89M

--152.31M

Current changes in cash

27.27%-13.89M

41.32%-19.1M

50.91%-32.55M

-231.14%-66.31M

--50.57M

Effect of exchange rate changes

164.02%274K

11.39%-428K

-320.55%-483K

4,280.00%219K

--5K

End cash Position

-16.17%70.61M

-18.82%84.23M

-24.15%103.76M

-32.58%136.79M

--202.89M

Free cash flow

-72.16%-34.91M

66.08%-20.28M

5.17%-59.79M

-106.87%-63.05M

---30.48M

Currency Unit

EUR

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-69.97%-32.56M	67.23%-19.16M	-12.92%-58.46M	-248.23%-51.77M	34.93M
Net income from continuing operations	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	---20.76M
Operating gains losses	156.31%308K	48.69%-547K	-309.02%-1.07M	157.63%510K	---885K
Depreciation and amortization	-88.79%5.09M	887.92%45.41M	-91.91%4.6M	243.62%56.8M	--16.53M
Other non cash items	-95.49%6K	114.35%133K	-301.52%-927K	-10.85%460K	--516K
Change In working capital	-156.67%-32.09M	-26.48%-12.5M	79.91%-9.89M	-222.26%-49.21M	--40.25M
Cash from discontinued investing activities
Operating cash flow	-69.97%-32.56M	67.23%-19.16M	-12.92%-58.46M	-248.23%-51.77M	--34.92M
Investing cash flow
Cash flow from continuing investing activities	999.09%20.63M	304.69%1.88M	93.14%-917K	78.48%-13.37M	-62.12M
Net PPE purchase and sale	62.43%-201K	41.97%-535K	-2.67%-922K	29.35%-898K	---1.27M
Net intangibles purchase and sale	-240.72%-2M	-46.38%-587K	96.13%-401K	83.82%-10.38M	---64.13M
Net investment purchase and sale	658.93%22.77M	--3M	--0	-250.00%-3M	--2M
Net other investing changes	6,500.00%64K	-102.56%-1K	166.10%39K	-490.00%-59K	---10K
Cash from discontinued investing activities
Investing cash flow	999.15%20.63M	304.69%1.88M	93.14%-917K	78.48%-13.37M	---62.12M
Financing cash flow
Cash flow from continuing financing activities	-7.55%-1.97M	-106.82%-1.83M	2,376.57%26.82M	-101.51%-1.18M	77.76M
Net issuance payments of debt	-16.54%-2.36M	-107.61%-2.03M	3,109.15%26.63M	-107.43%-885K	--11.92M
Net common stock issuance	----	----	----	----	--66.01M
Cash dividends paid	--0	--0	--0	--0	--0
Proceeds from stock option exercised by employees	99.49%395K	-60.32%198K	939.58%499K	9.09%48K	--44K
Net other financing activities	----	----	0.00%1K	0.00%1K	--1K
Cash from discontinued financing activities
Financing cash flow	-7.55%-1.97M	-106.82%-1.83M	2,378.59%26.82M	-101.51%-1.18M	--77.77M
Net cash flow
Beginning cash position	-18.82%84.23M	-24.15%103.76M	-32.58%136.79M	33.20%202.89M	--152.31M
Current changes in cash	27.27%-13.89M	41.32%-19.1M	50.91%-32.55M	-231.14%-66.31M	--50.57M
Effect of exchange rate changes	164.02%274K	11.39%-428K	-320.55%-483K	4,280.00%219K	--5K
End cash Position	-16.17%70.61M	-18.82%84.23M	-24.15%103.76M	-32.58%136.79M	--202.89M
Free cash flow	-72.16%-34.91M	66.08%-20.28M	5.17%-59.79M	-106.87%-63.05M	---30.48M
Currency Unit	EUR	EUR	EUR	EUR	EUR
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data